Dose Justification For [Fam-] Trastuzumab Deruxtecan (Ds-8201a) In Her2-Positive Breast CancerShunji Takahashi,Shanu Modi,Junji Tsurutani,Ian E. Krop,Hiroji Iwata,Russell Wada,Ophelia Yin,Tushar Garimella,Masahiro Sugihara,Lin Zhang,Caleb Lee,Kaku Saito,Yui Kawasaki,Antoine Yver,Kenji TamuraANNALS OF ONCOLOGY(2019)引用 2|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要